Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Q/C Technologies Q3 2026 Results: Net Loss of $942K, Loss Narrows

Q/C Technologies reported a net loss of $11.3 million for the nine months ended September 30, 2026, driven by significant stock-based compensation and a $3.2 million impairment of a technology license. The company remains pre-revenue, with its accumulated deficit increasing to $155.9 million and total stockholders' equity declining to $16.1 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Profit before tax-0.9-2.8
Net income-0.9-2.8
EPS (diluted, $ a share)$-0.14$-2.50

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, NASDAQ: QCLS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Q/C Technologies, Inc.: key numbers

Share price
$0.3210Close, Nov 16
Market cap
$2.77M
Shares outstanding
8.62MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Q/C Technologies, Inc.

All →
5:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Q/C Technologies Nasdaq/NYSE Compliance Notice

Q/C Technologies received a deficiency notice from Nasdaq on November 6, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, or until May 5, 2027, to regain compliance with the minimum bid price requirement. If compliance is not regained, the company may be eligible for an additional 180-day period or face delisting.

Counterparty
Nasdaq
Term
180 days
5:17 PM ET 8-K
Executive Compensation

Q/C Technologies Executive Compensation

Q/C Technologies appointed Dr. Yossef Ehrlichman as Chief Technology Officer and entered into an amended employment agreement. The agreement includes an annual base salary of $275,000 and a restricted stock award with a grant date fair market value of $250,000, subject to stockholder approval of a share reserve increase. Dr. Ehrlichman previously served as the company's Founding Manager of Photonic Integrated Circuit Development.

Counterparty
Yossef Ehrlichman
Term
at-will

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.